{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:43:23Z","timestamp":1783608203755,"version":"3.55.0"},"reference-count":27,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Annals of Clinical Psychiatry"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.12788\/acp.0107","type":"journal-article","created":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T17:17:03Z","timestamp":1682961423000},"page":"103-108","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":8,"title":["Electroconvulsive Therapy plus Lithium is Associated with Less Cognitive Impairment and Drug-Induced Delirium in Bipolar Depression Compared to Unipolar Depression"],"prefix":"10.1177","volume":"35","author":[{"given":"Nagy A.","family":"Youssef","sequence":"first","affiliation":[{"name":"Nagy A. Youssef, MD, PhD Department of Psychiatry and Behavioral Health The Ohio State University College of Medicine Columbus, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Madangarli","sequence":"additional","affiliation":[{"name":"Neha Madangarli, BS Department of Psychiatry and Health Behavior Medical College of Georgia at Augusta University Augusta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Bachu","sequence":"additional","affiliation":[{"name":"Anil Bachu, MD Department of Psychiatry Baptist Health Medical Center at the University of Arkansas for Medical Sciences North Little Rock, Arkansas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikinkumar S.","family":"Patel","sequence":"additional","affiliation":[{"name":"Rikinkumar S. Patel, MD, MPH Department of Psychiatry and Behavioral Sciences Duke University School of Medicine Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,3]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/bs.acc.2017.12.005"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psc.2015.10.001","article-title":"Discriminating between bipolar disorder and major depressive disorder","volume":"39","author":"V\u00f6hringer PA","year":"2016","unstructured":"V\u00f6hringerPA, PerlisRH. Discriminating between bipolar disorder and major depressive disorder. Psychiatr ClinNorth Am. 2016;39 (l):1\u201310.","journal-title":"Psychiatr ClinNorth Am"},{"issue":"2","key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ajmg.b.32680","article-title":"Biomarkers for major depressive and bipolar disorders using metabolomics: a systematic review","volume":"180","author":"MacDonald K","year":"2019","unstructured":"MacDonaldK, KrishnanA, CervenkaE, et al. Biomarkers for major depressive and bipolar disorders using metabolomics: a systematic review. Am J Med Genet B Neuro psychiatr Genet. 2019; 180 (2):122\u2013137.","journal-title":"Am J Med Genet B Neuro psychiatr Genet"},{"issue":"2","key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/104012371202400204","article-title":"Validation of a diagnostic screening blood test for bipolar disorder","volume":"24","author":"Woodruff DB","year":"2012","unstructured":"WoodruffDB, El-MallakhRS, ThiruvengadamAP. Validation of a diagnostic screening blood test for bipolar disorder. Ann Clin Psychiatry. 2012;24 (2):135\u2013139.","journal-title":"Ann Clin Psychiatry"},{"issue":"12","key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/mp.2016.3","article-title":"A metaanalysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression","volume":"21","author":"Goldsmith","year":"2016","unstructured":"GoldsmithDR, RapaportMH, MillerBJ. A metaanalysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry. 2016; 21 (12):1696\u20131709.","journal-title":"Mol Psychiatry"},{"issue":"8","key":"e_1_3_2_7_2","first-page":"500","article-title":"Combine these screening tools to detect bipolar depression","volume":"67","author":"Aquadro E","year":"2018","unstructured":"AquadroE, YoussefNA. Combine these screening tools to detect bipolar depression. J Fam Pract. 2018;67 (8):500\u2013503.","journal-title":"J Fam Pract"},{"issue":"1","key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/YCO.0000000000000122","article-title":"Reward processing dysfunction in major depression, bipolar disorder and schizophrenia","volume":"28","author":"Whitton AE","year":"2015","unstructured":"WhittonAE, TreadwayMT, PizzagalliDA. Reward processing dysfunction in major depression, bipolar disorder and schizophrenia. Curr Opin Psychiatry. 2015; 28 (1):7\u201312.","journal-title":"Curr Opin Psychiatry"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2013.08.014"},{"issue":"4","key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"el26","DOI":"10.1192\/bjo.2021.966","article-title":"Inflammatory biomarkers and cognitive functioning in individuals with euthymic bipolar disorder: exploratory study","volume":"7","author":"Strawbridge R","year":"2021","unstructured":"StrawbridgeR, CarterR, SaldariniF, et al. Inflammatory biomarkers and cognitive functioning in individuals with euthymic bipolar disorder: exploratory study. BJPsych Open. 2021;7 (4):el26.","journal-title":"BJPsych Open"},{"issue":"1","key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1176\/appi.ajp.2014.13111517","article-title":"Treatment-resistant bipolar depression: a randomized controlled trial of electroconvulsive therapy versus algorithm-based pharmacological treatment","volume":"172","author":"Schoeyen HK","year":"2015","unstructured":"SchoeyenHK, KesslerU, AndreassenOA, et al. Treatment-resistant bipolar depression: a randomized controlled trial of electroconvulsive therapy versus algorithm-based pharmacological treatment. Am J Psychiatry. 2015;172 (1):41\u201351.","journal-title":"Am J Psychiatry"},{"issue":"9","key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1176\/ajp.145.9.1178a","article-title":"Problems with lithium combined with ECT","volume":"145","author":"Milstein V","year":"1988","unstructured":"MilsteinV, SmallJG. Problems with lithium combined with ECT Am J Psychiatry. 1988;145 (9):1178.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"e_1_3_2_13_2","first-page":"103","article-title":"Complications with electroconvulsive treatment combined with lithium","volume":"15","author":"Small JG","year":"1980","unstructured":"SmallJG, KellamsJJ, MilsteinV, et al. Complications with electroconvulsive treatment combined with lithium. Biol Psychiatry. 1980;15 (1):103\u2013112.","journal-title":"Biol Psychiatry"},{"issue":"3","key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/01.yct.0000174383.96517.77","article-title":"The safety of electroconvulsive therapy and lithium in combination: a case series and review of the literature","volume":"21","author":"Dolenc TJ","year":"2005","unstructured":"DolencTJ, RasmussenKG. The safety of electroconvulsive therapy and lithium in combination: a case series and review of the literature. J ECT 2005; 21 (3):165\u2013170.","journal-title":"J ECT"},{"issue":"6","key":"e_1_3_2_15_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.genhosppsych.2013.01.011","article-title":"Delirium during the course of electroconvulsive therapy in a patient on lithium carbonate treatment","volume":"35","author":"Sadananda SK","year":"2013","unstructured":"SadanandaSK, NarayanaswamyJC, SrinivasarajuR, et al. Delirium during the course of electroconvulsive therapy in a patient on lithium carbonate treatment. Gen Hosp Psychiatry. 2013;35 (6):678.el-e2.","journal-title":"Gen Hosp Psychiatry"},{"issue":"11","key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1176\/ajp.137.11.1452","article-title":"Prolonged confusional state and EEG seizure activity following concurrent ECT and lithium use","volume":"137","author":"Weiner RD","year":"1980","unstructured":"WeinerRD, WhangerAD, ErwinCW, et al. Prolonged confusional state and EEG seizure activity following concurrent ECT and lithium use. Am J Psychiatry. 1980;137 (11):1452\u20131453.","journal-title":"Am J Psychiatry"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.brs.2019.08.012","article-title":"Combination of lithium and electroconvulsive therapy (ECT) is associated with higher odds of delirium and cognitive problems in a large national sample across the United States","volume":"13","author":"Patel RS","year":"2020","unstructured":"PatelRS, BachuA, YoussefNA. Combination of lithium and electroconvulsive therapy (ECT) is associated with higher odds of delirium and cognitive problems in a large national sample across the United States. Brain Stimul. 2020;13 (l):15\u201319.","journal-title":"Brain Stimul"},{"issue":"3","key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1399-5618.2012.01009.x","article-title":"Depression in bipolar disorder versus major depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"14","author":"Moreno C","year":"2012","unstructured":"MorenoC, HasinDS, ArangoC, et al. Depression in bipolar disorder versus major depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Bipolar Disord. 2012;14 (3):271\u2013282.","journal-title":"Bipolar Disord"},{"issue":"3","key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/154733251903100315","article-title":"A national study for regional variation of inpatient ECT utilization from 4,411 hospitals across the United States","volume":"31","author":"Patel RS","year":"2019","unstructured":"PatelRS, SreeramV, ThakurT, et al. A national study for regional variation of inpatient ECT utilization from 4,411 hospitals across the United States. Ann Clin Psychiatry. 2019;31 (3):200\u2013208.","journal-title":"Ann Clin Psychiatry"},{"key":"e_1_3_2_20_2","first-page":"43","article-title":"Tardive dyskinesia in affective disorders","volume":"60","author":"Kane JM.","year":"1999","unstructured":"KaneJM. Tardive dyskinesia in affective disorders. J Clin Psychiatry. 1999;60 Suppl 5:43\u201349.","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/JCP.0b013e318166c4d5","article-title":"Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review","volume":"28","author":"Gao K","year":"2008","unstructured":"GaoK, KempDE, GanocySJ, et al. Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review. J Clin Psychopharmacol. 2008;28 (2):203\u2013209.","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/JCP.0b013e3182917f3f","article-title":"Risk for adverse events and discontinuation due to adverse events of ziprasidone monotherapy relative to placebo in the acute treatment of bipolar depression, mania, and schizophrenia","volume":"33","author":"Gao K","year":"2013","unstructured":"GaoK, PappadopulosE, KarayalON, et al. Risk for adverse events and discontinuation due to adverse events of ziprasidone monotherapy relative to placebo in the acute treatment of bipolar depression, mania, and schizophrenia. J Clin Psychopharmacol. 2013;33 (3):425\u2013431.","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4088\/JCP.v69n0217","article-title":"A review of sensitivity and tolerability of antipsychotics in patients with bipolar disorder or schizophrenia: focus on somnolence","volume":"69","author":"Gao K","year":"2008","unstructured":"GaoK, GanocySJ, GajwaniP, et al. A review of sensitivity and tolerability of antipsychotics in patients with bipolar disorder or schizophrenia: focus on somnolence. J Clin Psychiatry. 2008;69 (2):302\u2013309.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1017\/S146114571000101X","article-title":"Comparisons of the tolerability and sensitivity of quetiapine-XR in the acute treatment of schizophrenia, bipolar mania, bipolar depression, major depressive disorder, and generalized anxiety disorder","volume":"14","author":"Wang Z","year":"2011","unstructured":"WangZ, KempDE, ChanPK, et al. Comparisons of the tolerability and sensitivity of quetiapine-XR in the acute treatment of schizophrenia, bipolar mania, bipolar depression, major depressive disorder, and generalized anxiety disorder. Int J Neuropsychopharmacol. 2011;14 (1): 131\u2013142.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"7","key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1038\/s41380-021-01061-w","article-title":"Precision medicine for mood disorders: objective assessment, risk prediction, pharmacogenomies, and repurposed drugs","volume":"26","author":"Le-Niculescu H","year":"2021","unstructured":"Le-NiculescuH, RoseberryK, GillSS, et al. Precision medicine for mood disorders: objective assessment, risk prediction, pharmacogenomies, and repurposed drugs. Mol Psychiatry. 2021; 26 (7):2776\u20132804.","journal-title":"Mol Psychiatry"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/sj.tpj.6500340","article-title":"Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder","volume":"6","author":"Hong CJ","year":"2006","unstructured":"HongCJ, ChenTJ, YuYW, et al. Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder. Pharmacogenomics J. 2006;6 (l):27\u201333.","journal-title":"Pharmacogenomics J"},{"issue":"7","key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.euroneuro.2005.12.004","article-title":"Association study of two serotonin 1A receptor gene polymorphisms and fluoxetine treatment response in Chinese major depressive disorders","volume":"16","author":"Yu YW","year":"2006","unstructured":"YuYW, TsaiSJ, LiouYJ, et al. Association study of two serotonin 1A receptor gene polymorphisms and fluoxetine treatment response in Chinese major depressive disorders. Eur Neuropsychopharmacol. 2006; 16 (7):498\u2013503.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"4","key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1017\/S1461145704004687","article-title":"The C(-1019) G polymorphism of the 5-HT1A gene promoter and antidepressant responseinmood disorders: preliminary findings","volume":"7","author":"Serretti A","year":"2004","unstructured":"SerrettiA, ArtioliP, LorenziC, et al. The C(-1019) G polymorphism of the 5-HT1A gene promoter and antidepressant responseinmood disorders: preliminary findings. Int J Neuropsychopharmacol. 2004;7 (4): 453\u2013460.","journal-title":"Int J Neuropsychopharmacol"}],"container-title":["Annals of Clinical Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.12788\/acp.0107","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.12788\/acp.0107","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.12788\/acp.0107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:06:13Z","timestamp":1757610373000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.12788\/acp.0107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["10.12788\/acp.0107"],"URL":"https:\/\/doi.org\/10.12788\/acp.0107","relation":{},"ISSN":["1040-1237","1547-3325"],"issn-type":[{"value":"1040-1237","type":"print"},{"value":"1547-3325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3]]}}}